These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 18353622
1. A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma. Ge J, Chen Z, Wu S, Yuan W, Hu B, Chen Z. Clin Oncol (R Coll Radiol); 2008 May; 20(4):275-83. PubMed ID: 18353622 [Abstract] [Full Text] [Related]
2. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer. Ito R, Oue N, Yoshida K, Kunimitsu K, Nakayama H, Nakachi K, Yasui W. Virchows Arch; 2005 Oct; 447(4):717-22. PubMed ID: 16044349 [Abstract] [Full Text] [Related]
3. Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer. Huang LP, Yu YH, Sheng C, Wang SH. Int J Gynecol Cancer; 2012 Sep; 22(7):1170-6. PubMed ID: 22810971 [Abstract] [Full Text] [Related]
4. Expression of Cdx2 and hepatocyte antigen in gastric carcinoma: correlation with histologic type and implications for prognosis. Fan Z, Li J, Dong B, Huang X. Clin Cancer Res; 2005 Sep 01; 11(17):6162-70. PubMed ID: 16144916 [Abstract] [Full Text] [Related]
5. Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis. Bai Z, Ye Y, Chen D, Shen D, Xu F, Cui Z, Wang S. APMIS; 2007 Dec 01; 115(12):1383-90. PubMed ID: 18184409 [Abstract] [Full Text] [Related]
6. [Expressions of homeobox transcription factor-2 and E-cadherin in gastric carcinoma and their clinical significance]. Ge J, Chen ZH, Chen ZK, Yuan WJ. Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb 01; 28(2):279-1281. PubMed ID: 18250063 [Abstract] [Full Text] [Related]
7. The predictive effect of cadherin-17 on lymph node micrometastasis in pN0 gastric cancer. Wang J, Yu JC, Kang WM, Wang WZ, Liu YQ, Gu P. Ann Surg Oncol; 2012 May 01; 19(5):1529-34. PubMed ID: 22009269 [Abstract] [Full Text] [Related]
8. CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach. Ko S, Chu KM, Luk JM, Wong BW, Yuen ST, Leung SY, Wong J. J Pathol; 2005 Apr 01; 205(5):615-22. PubMed ID: 15732140 [Abstract] [Full Text] [Related]
9. Expression and significance of homeodomain protein Cdx2 in gastric carcinoma and precancerous lesions. Qin R, Wang NN, Chu J, Wang X. World J Gastroenterol; 2012 Jul 07; 18(25):3296-302. PubMed ID: 22783055 [Abstract] [Full Text] [Related]
10. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma]. Xiong ZF, Xiao H, Tan YS. Zhonghua Bing Li Xue Za Zhi; 2010 Jul 07; 39(7):442-6. PubMed ID: 21055171 [Abstract] [Full Text] [Related]
11. Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer. Zhang X, Tsukamoto T, Mizoshita T, Ban H, Suzuki H, Toyoda T, Tatematsu M. Oncol Rep; 2009 Mar 07; 21(3):609-13. PubMed ID: 19212618 [Abstract] [Full Text] [Related]
12. CDH17 Is a More Sensitive Marker for Gastric Adenocarcinoma Than CK20 and CDX2. Altree-Tacha D, Tyrrell J, Haas T. Arch Pathol Lab Med; 2017 Jan 07; 141(1):144-150. PubMed ID: 28029907 [Abstract] [Full Text] [Related]
13. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2. Panarelli NC, Yantiss RK, Yeh MM, Liu Y, Chen YT. Am J Clin Pathol; 2012 Aug 07; 138(2):211-22. PubMed ID: 22904132 [Abstract] [Full Text] [Related]
14. CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype. Ha Kim G, Am Song G, Youn Park D, Han Lee S, Hyun Lee D, Oh Kim T, Jae Jo H, Heo J, Hwan Kang D, Cho M. Scand J Gastroenterol; 2006 Aug 07; 41(8):880-6. PubMed ID: 16803685 [Abstract] [Full Text] [Related]
15. Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populations. Schildberg CW, Abba M, Merkel S, Agaimy A, Dimmler A, Schlabrakowski A, Croner R, Leupold JH, Hohenberger W, Allgayer H. Adv Med Sci; 2014 Mar 07; 59(1):142-6. PubMed ID: 24797991 [Abstract] [Full Text] [Related]
16. Correlation of cadherin-17 protein expression with clinicopathological features and prognosis of patients with sporadic gastric cancer. Meng W, Gu T, Gao LM, Zong ZG, Meng L, Fu ZZ, Guo L. Braz J Med Biol Res; 2015 Dec 07; 48(12):1077-86. PubMed ID: 26421870 [Abstract] [Full Text] [Related]
17. [Expression of guanylyl cyclase-c and caudal type homeobox transcription factor 2 in human gastric cancer and precursor lesions]. Zhu HJ, Xu Z, Mao ZB, Zhang JF, Zhang JG, Pan ZP. Zhonghua Yi Xue Za Zhi; 2008 Dec 30; 88(48):3418-21. PubMed ID: 19159573 [Abstract] [Full Text] [Related]
18. Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma. Li Y, Chen CQ, He YL, Cai SR, Yang DJ, He WL, Xu JB, Zan WH. J Surg Oncol; 2012 Sep 01; 106(3):304-10. PubMed ID: 22231933 [Abstract] [Full Text] [Related]
19. Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis. Mizoshita T, Tsukamoto T, Nakanishi H, Inada K, Ogasawara N, Joh T, Itoh M, Yamamura Y, Tatematsu M. J Cancer Res Clin Oncol; 2003 Dec 01; 129(12):727-34. PubMed ID: 14557879 [Abstract] [Full Text] [Related]
20. HNF1α and CDX2 transcriptional factors bind to cadherin-17 (CDH17) gene promoter and modulate its expression in hepatocellular carcinoma. Zhu R, Wong KF, Lee NP, Lee KF, Luk JM. J Cell Biochem; 2010 Oct 15; 111(3):618-26. PubMed ID: 20568120 [Abstract] [Full Text] [Related] Page: [Next] [New Search]